KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incyte (INCY) Accumulated Expenses: 2010-2025

Historic Accumulated Expenses for Incyte (INCY) over the last 15 years, with Sep 2025 value amounting to $948.4 million.

  • Incyte's Accumulated Expenses fell 15.91% to $948.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $948.4 million, marking a year-over-year decrease of 15.91%. This contributed to the annual value of $1.2 billion for FY2024, which is 29.55% up from last year.
  • According to the latest figures from Q3 2025, Incyte's Accumulated Expenses is $948.4 million, which was up 10.66% from $857.1 million recorded in Q2 2025.
  • Incyte's 5-year Accumulated Expenses high stood at $1.4 billion for Q1 2025, and its period low was $413.1 million during Q2 2021.
  • Moreover, its 3-year median value for Accumulated Expenses was $948.4 million (2025), whereas its average is $1.0 billion.
  • As far as peak fluctuations go, Incyte's Accumulated Expenses soared by 45.23% in 2022, and later fell by 17.13% in 2025.
  • Incyte's Accumulated Expenses (Quarterly) stood at $533.6 million in 2021, then spiked by 31.38% to $701.1 million in 2022, then skyrocketed by 33.45% to $935.6 million in 2023, then grew by 29.55% to $1.2 billion in 2024, then dropped by 15.91% to $948.4 million in 2025.
  • Its Accumulated Expenses stands at $948.4 million for Q3 2025, versus $857.1 million for Q2 2025 and $1.4 billion for Q1 2025.